Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Activation of nicotinic acetylcholine receptors induces potentiation and synchronization within in vitro hippocampal networks.

Tytuł:
Activation of nicotinic acetylcholine receptors induces potentiation and synchronization within in vitro hippocampal networks.
Autorzy:
Djemil S; Department of Pharmacology and Physiology, Georgetown University Medical Center, Washington, DC, USA.
Chen X; Department of Physics, Georgetown University, Washington, DC, USA.
Zhang Z; Department of Physics, Georgetown University, Washington, DC, USA.
Lee J; Department of Pharmacology and Physiology, Georgetown University Medical Center, Washington, DC, USA.
Rauf M; Department of Human Science, Georgetown University Medical Center, Washington, DC, USA.
Pak DTS; Department of Pharmacology and Physiology, Georgetown University Medical Center, Washington, DC, USA.; Interdisciplinary Program in Neuroscience, Georgetown University Medical Center, Washington, DC, USA.
Dzakpasu R; Department of Pharmacology and Physiology, Georgetown University Medical Center, Washington, DC, USA.; Department of Physics, Georgetown University, Washington, DC, USA.; Interdisciplinary Program in Neuroscience, Georgetown University Medical Center, Washington, DC, USA.
Źródło:
Journal of neurochemistry [J Neurochem] 2020 May; Vol. 153 (4), pp. 468-484. Date of Electronic Publication: 2019 Dec 29.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
Język:
English
Imprint Name(s):
Publication: 2001- : Oxford, UK : Wiley on behalf of the International Society for Neurochemistry
Original Publication: New York : Raven Press
MeSH Terms:
Hippocampus/*metabolism
Long-Term Potentiation/*physiology
Nerve Net/*metabolism
Receptors, Nicotinic/*metabolism
Animals ; Cells, Cultured ; Dose-Response Relationship, Drug ; Female ; Hippocampus/drug effects ; Long-Term Potentiation/drug effects ; Nerve Net/drug effects ; Nicotine/pharmacology ; Nicotinic Agonists/pharmacology ; Pregnancy ; Rats ; Rats, Sprague-Dawley
References:
J Neurophysiol. 1997 Nov;78(5):2631-40. (PMID: 9356412)
Annu Rev Neurosci. 1999;22:443-85. (PMID: 10202545)
Curr Top Med Chem. 2004;4(3):283-97. (PMID: 14754448)
J Neurosci Methods. 2012 Jan 30;203(2):344-53. (PMID: 21985763)
Eur J Neurosci. 2009 Sep;30(6):1011-22. (PMID: 19735287)
Trends Neurosci. 1996 May;19(5):202-8. (PMID: 8723208)
Neuron. 2000 Aug;27(2):349-57. (PMID: 10985354)
J Physiol. 2003 Sep 1;551(Pt 2):539-50. (PMID: 12815181)
J Neural Transm (Vienna). 2007 Jan;114(1):135-47. (PMID: 16906354)
Cereb Cortex. 2002 Sep;12(9):893-9. (PMID: 12183388)
J Neurophysiol. 2001 Dec;86(6):3043-55. (PMID: 11731559)
Front Synaptic Neurosci. 2013 Jul 30;5:2. (PMID: 23908628)
Int Rev Neurobiol. 2015;124:3-19. (PMID: 26472524)
PLoS One. 2012;7(8):e42631. (PMID: 22912716)
Front Neural Circuits. 2017 Dec 13;11:102. (PMID: 29321728)
Nat Neurosci. 2019 Feb;22(2):154-166. (PMID: 30664773)
J Comp Neurol. 1983 Feb 20;214(2):170-97. (PMID: 6841683)
J Neurobiol. 2002 Dec;53(4):457-78. (PMID: 12436413)
Neuron. 2003 Jun 19;38(6):929-39. (PMID: 12818178)
Mol Pharmacol. 2006 Oct;70(4):1454-60. (PMID: 16857741)
Annu Rev Pharmacol Toxicol. 2007;47:699-729. (PMID: 17009926)
Synapse. 1993 Jul;14(3):214-20. (PMID: 8105548)
Proc Natl Acad Sci U S A. 2009 Jun 16;106(24):9854-9. (PMID: 19482936)
J Physiol. 2005 Jan 1;562(Pt 1):81-8. (PMID: 15528238)
Cold Spring Harb Perspect Med. 2015 Nov 02;5(11):. (PMID: 26525454)
Neuron. 2001 Oct 11;32(1):141-9. (PMID: 11604145)
Nat Rev Neurosci. 2002 Mar;3(3):175-90. (PMID: 11994750)
Curr Mol Pharmacol. 2008 Jun;1(2):106-29. (PMID: 20021427)
J Pharmacol Exp Ther. 1993 Jun;265(3):1455-73. (PMID: 8510022)
Phys Rev E Stat Nonlin Soft Matter Phys. 2010 Sep;82(3 Pt 1):031907. (PMID: 21230108)
J Neurosci. 2010 Nov 24;30(47):15927-42. (PMID: 21106831)
Nat Rev Neurosci. 2010 Feb;11(2):100-13. (PMID: 20087360)
Proc Natl Acad Sci U S A. 2016 Aug 16;113(33):E4920-7. (PMID: 27482106)
Trends Neurosci. 2003 Mar;26(3):161-7. (PMID: 12591219)
Brain Res. 1986 Nov 29;398(2):242-52. (PMID: 3026567)
J Neurophysiol. 2002 Mar;87(3):1651-4. (PMID: 11877536)
Science. 2004 Jun 25;304(5679):1926-9. (PMID: 15218136)
J Neural Eng. 2010 Oct;7(5):056001. (PMID: 20720282)
Neuron. 2002 Jan 31;33(3):325-40. (PMID: 11832222)
Psychopharmacology (Berl). 2006 Mar;184(3-4):292-305. (PMID: 16001117)
J Neurophysiol. 2016 Jun 1;115(6):3073-89. (PMID: 26984425)
Brain Res Mol Brain Res. 1993 Jan;17(1-2):59-69. (PMID: 8381910)
Behav Brain Res. 2000 Aug;113(1-2):21-34. (PMID: 10942029)
Biochim Biophys Acta. 2002 Nov 4;1600(1-2):148-53. (PMID: 12445470)
Dialogues Clin Neurosci. 2012 Dec;14(4):345-67. (PMID: 23393413)
Mol Pharmacol. 2003 Feb;63(2):332-41. (PMID: 12527804)
J Pharmacol Exp Ther. 1990 Jan;252(1):15-20. (PMID: 2299587)
Phys Rev E Stat Nonlin Soft Matter Phys. 2001 Jul;64(1 Pt 1):011920. (PMID: 11461301)
J Neurosci. 1997 Jul 1;17(13):5196-205. (PMID: 9185557)
Brain Res. 2001 Mar 16;894(2):347-53. (PMID: 11251214)
J Physiol. 1999 Jul 1;518(Pt 1):131-40. (PMID: 10373695)
Behav Brain Res. 2017 Aug 30;333:251-257. (PMID: 28693859)
J Neurochem. 1996 Nov;67(5):1953-9. (PMID: 8863500)
Hippocampus. 1994 Jun;4(3):281-5. (PMID: 7842050)
Prog Neurobiol. 2010 Oct;92(2):105-11. (PMID: 20558239)
J Neurosurg Anesthesiol. 2012 Oct;24(4):368-75. (PMID: 23085784)
J Pharmacol Exp Ther. 2005 Mar;312(3):1213-22. (PMID: 15523001)
Hippocampus. 1991 Apr;1(2):181-92. (PMID: 1669292)
Learn Mem. 1999 Mar-Apr;6(2):138-52. (PMID: 10327239)
Neuropharmacology. 1999 Oct;38(10):1493-503. (PMID: 10530811)
J Biol Chem. 2015 Aug 14;290(33):20060-70. (PMID: 26088141)
J Neurosci. 2001 Oct 15;21(20):7993-8003. (PMID: 11588172)
J Neurosci. 1985 May;5(5):1307-15. (PMID: 3998824)
Exp Neurol. 1973 Nov;41(2):532-55. (PMID: 4795728)
J Physiol. 1999 Jul 15;518 ( Pt 2):571-6. (PMID: 10381601)
Eur J Neurosci. 2013 Jun;37(12):1896-902. (PMID: 23773058)
Neuropharmacology. 2002 May;42(6):741-51. (PMID: 12015200)
Ann N Y Acad Sci. 1999 Apr 30;868:591-610. (PMID: 10414340)
J Neurosci. 2011 Sep 21;31(38):13546-61. (PMID: 21940446)
Nature. 1995 Nov 2;378(6552):75-8. (PMID: 7477292)
J Physiol. 2012 Feb 15;590(4):655-66. (PMID: 22124144)
IEEE Trans Biomed Eng. 1992 Jan;39(1):37-42. (PMID: 1572679)
Neuron. 2013 Jan 9;77(1):99-114. (PMID: 23312519)
Neuropharmacology. 2015 Jun;93:229-36. (PMID: 25689019)
Trends Neurosci. 1997 Jan;20(1):38-43. (PMID: 9004418)
Eur J Neurosci. 2006 Dec;24(11):3109-18. (PMID: 17156372)
J Comp Neurol. 1988 Jun 1;272(1):127-38. (PMID: 3385020)
Prog Neurobiol. 1993 Aug;41(2):157-208. (PMID: 8332751)
J Pharmacol Exp Ther. 1994 Oct;271(1):494-506. (PMID: 7525930)
Mol Pharmacol. 2017 Sep;92(3):327-337. (PMID: 28698187)
J Neurosci. 2011 Sep 28;31(39):13710-21. (PMID: 21957234)
Front Cell Neurosci. 2015 Jan 14;8:460. (PMID: 25642167)
Nature. 1996 Oct 24;383(6602):713-6. (PMID: 8878480)
J Physiol. 2005 Apr 1;564(Pt 1):3-19. (PMID: 15618268)
Exp Neurol. 1975 Oct;49(1 Pt 1):58-85. (PMID: 1183532)
Nat Commun. 2016 Nov 04;7:13249. (PMID: 27811848)
Neuron. 1998 Jul;21(1):179-89. (PMID: 9697862)
Neuroscience. 1999;88(3):755-64. (PMID: 10363815)
Pharmacol Ther. 2009 Jun;122(3):302-11. (PMID: 19351547)
Mol Pharmacol. 2015 Oct;88(4):640-9. (PMID: 26162864)
J Neurophysiol. 2000 May;83(5):2682-90. (PMID: 10805668)
Nat Neurosci. 2001 Jun;4(6):565-6. (PMID: 11369935)
J Neurosci. 1993 Jun;13(6):2680-8. (PMID: 8501532)
J Neurosci. 1988 Aug;8(8):2967-85. (PMID: 2842468)
Psychopharmacology (Berl). 1988;95(1):52-5. (PMID: 3133700)
BMC Neurosci. 2006 Feb 07;7:11. (PMID: 16464257)
AAPS J. 2009 Mar;11(1):167-77. (PMID: 19280351)
Neuroscience. 2002;115(4):1089-108. (PMID: 12453482)
J Neurosci. 2011 Mar 30;31(13):4978-90. (PMID: 21451036)
Biochem Pharmacol. 1969 Sep;18(9):2145-52. (PMID: 5345889)
Prog Brain Res. 2004;145:109-20. (PMID: 14650910)
Synapse. 2004 Dec 15;54(4):200-6. (PMID: 15472930)
J Physiol. 1987 Jul;388:611-29. (PMID: 3656200)
Biochem Pharmacol. 2014 May 1;89(1):1-11. (PMID: 24486571)
Biochem Pharmacol. 2013 Oct 15;86(8):1145-52. (PMID: 23928190)
Neuropharmacology. 2002 Aug;43(2):131-40. (PMID: 12213267)
Trends Neurosci. 2000 Jul;23(7):305-12. (PMID: 10856940)
J Neurosci. 2007 Mar 14;27(11):2846-57. (PMID: 17360906)
Trends Neurosci. 1997 Feb;20(2):92-8. (PMID: 9023878)
J Neurosci Methods. 1988 Mar;23(2):149-59. (PMID: 3357355)
Neuron. 2003 Jul 17;39(2):283-97. (PMID: 12873385)
J Physiol. 2005 Jan 1;562(Pt 1):9-26. (PMID: 15539390)
J Physiol. 2006 May 1;572(Pt 3):789-98. (PMID: 16513670)
J Neurosci Methods. 2001 Sep 30;110(1-2):17-24. (PMID: 11564520)
J Mol Neurosci. 2006;30(1-2):137-40. (PMID: 17192660)
PLoS One. 2013 Nov 14;8(11):e79653. (PMID: 24244538)
Curr Opin Neurobiol. 2000 Apr;10(2):172-9. (PMID: 10753798)
Front Synaptic Neurosci. 2014 Oct 27;6:24. (PMID: 25386136)
Nature. 1998 Jun 25;393(6687):793-7. (PMID: 9655394)
Neuron. 1996 Apr;16(4):815-23. (PMID: 8607999)
Biol Psychiatry. 2001 Feb 1;49(3):258-67. (PMID: 11230877)
J Neurophysiol. 2012 Nov;108(9):2568-80. (PMID: 22972961)
Hippocampus. 1996;6(4):347-470. (PMID: 8915675)
Annu Rev Physiol. 1993;55:349-74. (PMID: 8466179)
Cell Tissue Res. 1986;246(2):293-301. (PMID: 3779810)
Sci Rep. 2015 Sep 15;5:14099. (PMID: 26370265)
Nature. 2006 Oct 19;443(7113):768-73. (PMID: 17051202)
Neuron. 2001 Aug 2;31(2):289-303. (PMID: 11502259)
Neurobiol Aging. 2012 Jul;33(7):1481.e13-23. (PMID: 22227005)
J Med Chem. 2010 Nov 25;53(22):8187-91. (PMID: 20979364)
Grant Information:
RF1 AG056603 United States AG NIA NIH HHS; TL1 TR001431-01 United States AG NIA NIH HHS; RF1 AG056603-01 United States AG NIA NIH HHS; TL1 TR001431 United States TR NCATS NIH HHS
Contributed Indexing:
Keywords: in vitro hippocampal networks; micro-electrode arrays; neural network dynamics; nicotine; nicotinic acetylcholine receptors
Substance Nomenclature:
0 (Nicotinic Agonists)
0 (Receptors, Nicotinic)
6M3C89ZY6R (Nicotine)
Entry Date(s):
Date Created: 20191211 Date Completed: 20201028 Latest Revision: 20210502
Update Code:
20240105
PubMed Central ID:
PMC7239735
DOI:
10.1111/jnc.14938
PMID:
31821553
Czasopismo naukowe
Nicotinic acetylcholine receptors (nAChRs) are known to play a role in cognitive functions of the hippocampus, such as memory consolidation. Given that they conduct Ca 2+ and are capable of regulating the release of glutamate and γ-aminobutyric acid (GABA) within the hippocampus, thereby shifting the excitatory-inhibitory ratio, we hypothesized that the activation of nAChRs will result in the potentiation of hippocampal networks and alter synchronization. We used nicotine as a tool to investigate the impact of activation of nAChRs on neuronal network dynamics in primary embryonic rat hippocampal cultures prepared from timed-pregnant Sprague-Dawley rats. We perturbed cultured hippocampal networks with increasing concentrations of bath-applied nicotine and performed network extracellular recordings of action potentials using a microelectrode array. We found that nicotine modulated network dynamics in a concentration-dependent manner; it enhanced firing of action potentials as well as facilitated bursting activity. In addition, we used pharmacological agents to determine the contributions of discrete nAChR subtypes to the observed network dynamics. We found that β4-containing nAChRs are necessary for the observed increases in spiking, bursting, and synchrony, while the activation of α7 nAChRs augments nicotine-mediated network potentiation but is not necessary for its manifestation. We also observed that antagonists of N-methyl-D-aspartate receptors (NMDARs) and group I metabotropic glutamate receptors (mGluRs) partially blocked the effects of nicotine. Furthermore, nicotine exposure promoted autophosphorylation of Ca 2+ /calmodulin-dependent kinase II (CaMKII) and serine 831 phosphorylation of the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) subunit GluA1. These results suggest that nicotinic receptors induce potentiation and synchronization of hippocampal networks and glutamatergic synaptic transmission. Findings from this work highlight the impact of cholinergic signaling in generating network-wide potentiation in the form of enhanced spiking and bursting dynamics that coincide with molecular correlates of memory such as increased phosphorylation of CaMKII and GluA1. OPEN SCIENCE BADGES: This article has received a badge for *Open Materials* because it provided all relevant information to reproduce the study in the manuscript. More information about the Open Practices badges can be found at https://cos.io/our-services/open-science-badges/.
(© 2019 International Society for Neurochemistry.)

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies